(IBDX) iShares Trust - iShares - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US46436E3128 • Target Maturity
IBDX: Fixed, Income, Securities, Corporate, Bonds, Target, Maturity
The iShares iBonds Dec 2032 Term Corporate ETF (IBDX) is designed to track the performance of investment-grade corporate bonds maturing in 2032. The fund may invest in securities of non-U.S. issuers to align with its underlying index. It allocates at least 80% of its assets to index components and at least 90% to fixed income securities consistent with the index. The ETF is non-diversified, meaning it can concentrate holdings in fewer issuers.
Technically, IBDX shows a sideways trend with support near its 20-day SMA of 24.58 and resistance at its 50-day SMA of 24.65. The 200-day SMA at 24.45 suggests longer-term stability. Average trading volume of 133,400 shares indicates moderate liquidity. The ATR of 0.21 reflects low price volatility. Fundamentally, with AUM of $1.022 billion, the ETF demonstrates investor interest in its target maturity strategy. Expect IBDX to remain range-bound near current levels, with potential upside driven by its alignment to the 20-day SMA and continued demand for corporate bonds with defined maturities.
Additional Sources for IBDX ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
IBDX ETF Overview
Market Cap in USD | 1,022m |
Category | Target Maturity |
TER | 0.10% |
IPO / Inception | 2022-06-28 |
IBDX ETF Ratings
Growth Rating | 40.8 |
Fundamental | - |
Dividend Rating | 67.8 |
Rel. Strength | -3.72 |
Analysts | - |
Fair Price Momentum | 24.77 USD |
Fair Price DCF | - |
IBDX Dividends
Dividend Yield 12m | 4.64% |
Yield on Cost 5y | 5.18% |
Annual Growth 5y | 28.83% |
Payout Consistency | 100.0% |
IBDX Growth Ratios
Growth Correlation 3m | 35.4% |
Growth Correlation 12m | 57.7% |
Growth Correlation 5y | 84.7% |
CAGR 5y | 4.18% |
CAGR/Max DD 5y | 0.33 |
Sharpe Ratio 12m | 0.55 |
Alpha | 2.21 |
Beta | 0.019 |
Volatility | 7.38% |
Current Volume | 120.5k |
Average Volume 20d | 122.1k |
As of May 09, 2025, the stock is trading at USD 24.70 with a total of 120,456 shares traded.
Over the past week, the price has changed by -0.36%, over one month by +1.74%, over three months by +1.38% and over the past year by +6.53%.
Partly, yes. Based on ValueRay Analyses, iShares Trust - iShares (NYSE ARCA:IBDX) is currently (May 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 40.78 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of IBDX as of May 2025 is 24.77. This means that IBDX is currently overvalued and has a potential downside of 0.28%.
iShares Trust - iShares has no consensus analysts rating.
According to ValueRays Forecast Model, IBDX iShares Trust - iShares will be worth about 26.8 in May 2026. The stock is currently trading at 24.70. This means that the stock has a potential upside of +8.3%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 26.8 | 8.3% |